The Recombinant DNA Technology Market report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2031.
The Recombinant DNA Technology Market report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint.
The global recombinant DNA technology market report has been segmented on the basis of component, product, application, end-user, and region.
Recombinant DNA Technology Market Overview:
“The Recombinant DNA Technology Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031.”
Recombinant DNA technology joints together DNA molecules from two various species which are then inserted into the host organism to produce a new genetic combination having a wide application in medicine, agriculture, and industry.
Basic tools required in recombinant DNA technology include the enzymes, the vectors, and the host organism. Recombinant DNA technology has a wide application in the agriculture industry; for the manufacturing of Bt-cotton that protects the plants against ball worms.
It is widely used in the manufacturing of medicine, gene therapy, and clinical diagnosis.
Increasing demand for recombinant and genetically modified products for human health, food, and agriculture is expected to drive the market growth of the global recombinant DNA technology market over the forecast period.
Furthermore, increasing government funding regarding the use of recombinant DNA technology to solve the various food, healthcare, and environmental issues is further expected to fuel market growth.
Manufacturing companies focusing on developing products by using recombinant DNA technology for various chronic diseases are expected to propel market growth over the forecast period.
However, ethical challenges associated with gene therapy and stringent regulations for approval of the product are expected to hamper the market growth over the forecast period.
North American market dominates the global recombinant DNA technology market in terms of revenue contribution as compared to that of markets in other regions.
This is attributed to the presence of well-developed healthcare infrastructure and the presence of a large number of manufacturers in the region.
Europe accounts for the second-largest revenue share contribution to the global recombinant DNA technology market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively.
The market in the Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years owing to the improving healthcare infrastructure, increasing the number of research institutes, and government funding in the region.
Global Recombinant DNA Technology Market Segmentation:
Global recombinant DNA technology market segmentation, by component:
- Expression System
- Baculovirus / Insect
- Cloning Vector
Global recombinant DNA technology market segmentation, by-product:
- Therapeutic Agent
- Human Protein
- Biotech Crops
Global recombinant DNA technology market segmentation, by application:
- Health and Disease
- Food and Agriculture
Global recombinant DNA technology s market segmentation, by end-user:
- Biotechnology and Pharmaceutical Companies
- Academic & Government Research Institutes
Global recombinant DNA technology s market segmentation, by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Monsanto Company
- Hoffmann-La Roche AG
- Biogen Inc.
- Amgen Inc.
- Novartis AG
- Eli Lilly and Company
- Novo Nordisk A/S
- Sanofi SA
- Merck & Co., Inc.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!